Cargando…

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications

BACKGROUND: Human papillomavirus (HPV) testing is more sensitive than cytology for detecting high-grade cervical intraepithelial neoplasia (CIN). We evaluated the performance of high-risk HPV (hrHPV) testing in routine screening. METHODS: In all, 25 871 women (29–61) enrolled in our population-based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rijkaart, D C, Berkhof, J, van Kemenade, F J, Coupe, V M H, Rozendaal, L, Heideman, D A M, Verheijen, R H M, Bulk, S, Verweij, W, Snijders, P J F, Meijer, C J L M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305964/ https://www.ncbi.nlm.nih.gov/pubmed/22251922 http://dx.doi.org/10.1038/bjc.2011.581

Ejemplares similares

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
por: Bulk, S, et al.
Publicado: (2006)

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test
por: Rijkaart, D C, et al.
Publicado: (2010)

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening
por: Coupé, V M H, et al.
Publicado: (2008)

High-risk HPV type-specific clearance rates in cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2007)

The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency
por: Bulk, S, et al.
Publicado: (2007)

HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test
por: Polman, Nicole J, et al.
Publicado: (2017)

Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area
por: Bulk, S, et al.
Publicado: (2003)

HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study
por: Gök, Murat, et al.
Publicado: (2010)

Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2005)

HPV infection in women with and without cervical cancer in Conakry, Guinea
por: Keita, N, et al.
Publicado: (2009)

Risk of cervical precancer among HPV–negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study
por: Inturrisi, Federica, et al.
Publicado: (2022)

Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening
por: Verhoef, Lisanne, et al.
Publicado: (2023)

Extended duration of the detectable stage by adding HPV test in cervical cancer screening
por: van den Akker-van Marie, M E, et al.
Publicado: (2003)

Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases
por: Gök, M, et al.
Publicado: (2011)

Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV‐positive women: Results from a Dutch primary HPV‐based screening cohort
por: Verhoef, Lisanne, et al.
Publicado: (2021)

Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study
por: Uijterwaal, M H, et al.
Publicado: (2014)

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012)

Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study
por: Mesher, D, et al.
Publicado: (2010)

HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study
por: Palmer, T J, et al.
Publicado: (2016)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women
por: Luttmer, Roosmarijn, et al.
Publicado: (2016)

HPV immunisation and increased uptake of cervical screening in Scottish women; observational study of routinely collected national data
por: Palmer, T J, et al.
Publicado: (2016)

Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study
por: Inturrisi, Federica, et al.
Publicado: (2021)

Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, Tanzania
por: Cunningham, Melissa S, et al.
Publicado: (2015)

Oral HPV16 DNA as a screening tool to detect early oropharyngeal squamous cell carcinoma
por: Tang, Kai D., et al.
Publicado: (2020)

Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders
por: Lam, J. U. H., et al.
Publicado: (2017)

HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears
por: Zielinski, G D, et al.
Publicado: (2001)

Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study
por: Babion, Iris, et al.
Publicado: (2018)

Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea
por: Choi, K S, et al.
Publicado: (2015)

Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm
por: Geraghty, J, et al.
Publicado: (2014)

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
por: Kavanagh, K, et al.
Publicado: (2014)

Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel
por: Polman, N. J., et al.
Publicado: (2017)

Immediate and delayed effects of mammographic screening on breast cancer mortality and incidence in birth cohorts
por: Ripping, T M, et al.
Publicado: (2013)

Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia
por: Nobbenhuis, M A E, et al.
Publicado: (2001)

Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women
por: Muñoz, N, et al.
Publicado: (2009)

Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up
por: De Strooper, Lise M.A., et al.
Publicado: (2018)

Resilience of a FIT screening programme against screening fatigue: a modelling study
por: Greuter, Marjolein J. E., et al.
Publicado: (2016)

Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping
por: Dick, Stèfanie, et al.
Publicado: (2021)

Papillomavirus infection in rural women in southern India
por: Franceschi, S, et al.
Publicado: (2005)

Trends in breast biopsies for abnormalities detected at screening mammography: a population-based study in the Netherlands
por: van Breest Smallenburg, V, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0ichj516bd1t5mvhv20ah1gh95